Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 6/20 | 0.51 |
| ▸ | HTR2C | P28335 | 3/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 3/20 | 0.43 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | GRM5 | P41594 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26286122 | 0.79 | HSD11B1 (0.51) | HTR2CHTR2BCNR1HTR2AKCNH2 | |
| SCHEMBL2055459 | 0.74 | ACLY (0.44) | ACLYCNR1GRM5 | |
| SCHEMBL31646754 | 0.74 | ACLY (0.52) | ACLYHTR2CHTR2BCNR1KAT6A | |
| SCHEMBL3446333 | 0.73 | CNR1 (0.58) | HTR2CHTR2BCNR1HTR2ACNR2 | |
| SCHEMBL31208000 | 0.72 | NAMPT (0.45) | ACLYGRM5 | |
| SCHEMBL13343182 | 0.70 | CNR1 (0.58) | ACLYCNR1CNR2 | |
| SCHEMBL776706 | 0.69 | HTR6 (0.57) | HTR2CHTR2BCNR1HTR2AKCNH2 | |
| SCHEMBL21930895 | 0.68 | ACLY (1.00) | ACLY | |
| SCHEMBL30333632 | 0.68 | AKR1B1 (0.53) | HTR2CHTR2BCNR1HTR2ACNR2 | |
| SCHEMBL2124755 | 0.68 | AKR1B1 (0.53) | HTR2CHTR2BCNR1HTR2ACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025131957-A1 | DIAZINONE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS | BASF SE (DE) | 2025-06-26 | — | — | WO | disclosed |